Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 12071476 IL-6 antibodies and fusion constructs and conjugates thereof

Patent 12071476 was granted and assigned to Kodiak Sciences on August, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 28 Aug, 2024
"Created via: Patent importer"
Golden AI profile picture
Golden AI
created this topic on 28 Aug, 2024
Edits made to:
Infobox (+212 properties)
Article (+303 characters)
‌

 US Patent 12071476 IL-6 antibodies and fusion constructs and conjugates thereof

Article

Patent abstract

The present invention provides antagonizing antibodies that bind to IL-6, fusion proteins thereof with VEGF Trap, and conjugates of either thereof, and methods of using same. The anti-IL-6 antibodies can be used therapeutically alone or in combination with other therapeutics to diseases.

Infobox
Is a
Patent
Patent
0
Patent Applicant
Kodiak Sciences
Kodiak Sciences
0
Current Assignee
Kodiak Sciences
Kodiak Sciences
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
120714760
Patent Inventor Names
Daniel Victor Perlroth0
Fernando Corrêa0
Hong Liang0
Rachel D. Jacobson0
Date of Patent
August 27, 2024
0
Patent Application Number
162901280
Date Filed
March 1, 2019
0
Patent Citations
‌
US Patent 11155610 Dual PDGF/VEGF antagonists
0
‌
US Patent 7122636 Antibody fragment-polymer conjugates and uses of same
0
‌
US Patent 7125938 Atom or group transfer radical polymerization
0
‌
US Patent 7157530 Catalyst system for controlled polymerization
0
‌
US Patent 7169901 Anti-VEGF antibodies
0
‌
US Patent 7214776 Antibody fragment-polymer conjugates and uses of same
0
‌
US Patent 7291721 Anti-IL-6 antibodies, compositions, methods and uses
0
‌
US Patent 7297334 Anti-vegf antibodies
0
‌
US Patent 7300653 Method of treating corneal transplant rejection
0
‌
US Patent 7300990 Zwitterionic polymers
0
‌
US Patent 7303748 Method of treating eye injury with local administration of a VEGF inhibitor
0
‌
US Patent 7306799 Use of VEGF inhibitors for treatment of eye disorders
0
‌
US Patent 7345027 Compositions and methods for siRNA inhibition of angiogenesis
0
‌
US Patent 7348424 Polysaccharide containing phosphorylcholine group and process for producing the same
0
‌
US Patent 7351411 Methods of treating anemia by inhibition of vascular endothelial growth factor (VEGF)
0
‌
US Patent 7354578 Method of tumor regression with VEGF inhibitors
0
‌
US Patent 7354579 Method of treating cancer with a VEGF antagonist and an anti-proliferative agent
0
‌
US Patent 7354580 Method of administering and using VEGF inhibitors for the treatment of human cancer
0
‌
US Patent 7354581 Therapeutic combination of a VEGF antagonist and anti-hypertensive agent
0
‌
US Patent 7354582 Use of VEGF antagonists for the treatment of malignant gliomas
0
‌
US Patent 7365166 Anti-VEGF antibodies
0
‌
US Patent 7374757 Modified chimeric polypeptides with improved pharmacokinetic properties
0
‌
US Patent 7375193 Anti-VEGF antibodies
0
‌
US Patent 7378095 Methods of treating type I diabetes by blocking VEGF-mediated activity
0
‌
US Patent 7507405 Antibody fragment-polymer conjugates and uses of same
0
‌
US Patent 7521541 Cysteine engineered antibodies and conjugates
0
‌
US Patent 7531172 Methods of treating diseases with a VEGF antagonist
0
‌
US Patent 7560112 Anti-il-6 antibodies, compositions, methods and uses
0
‌
US Patent 7569655 Biologically absorbable coatings for implantable devices based on polyesters and methods for fabricating the same
0
‌
US Patent 7608261 VEGF antagonist formulations suitable for intravitreal administration
0
‌
US Patent 7612182 Anti-IL-6 antibodies, compositions, methods and uses
0
‌
US Patent 7740844 Anti-VEGF monoclonal antibody
0
‌
US Patent 7740850 PDGFRβ-specific antibodies
0
‌
US Patent 7750138 Angiogenesis-inhibiting chimeric protein and the use
0
‌
US Patent 7754208 Binding domain-immunoglobulin fusion proteins
0
‌
US Patent 7754855 Immunoglobulin fusion proteins
0
‌
US Patent 7758859 Anti-VEGF antibodies
0
‌
US Patent 7759472 Combination therapy for the treatment of ocular neovascular disorders
0
‌
US Patent 7842789 Antibody fragment-polymer conjugates and uses of same
0
‌
US Patent 7855178 Growth factor binding constructs materials and methods
0
‌
US Patent 7893173 Polymerization process with catalyst reactivation
0
‌
US Patent 7919099 Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides
0
‌
US Patent 7928072 Multimeric constructs
0
‌
US Patent 7955597 Anti-IL-6 antibodies, compositions, methods and uses
0
‌
US Patent 8003097 Treatment of cerebral amyloid angiopathy
0
‌
US Patent 8007798 Treatment of complement-associated disorders
0
‌
US Patent 8007799 Vascular endothelial cell growth factor antagonists and uses thereof
0
‌
US Patent 8008453 Modified Fc molecules
0
‌
US Patent 8034905 Anti-VEGF antibody compositions and methods
0
‌
US Patent 8048418 Therapeutic methods for inhibiting tumor growth with combination of Dll4 antagonists and VEGF antagonists
0
‌
US Patent 8067002 Humanized anti-factor D antibodies
0
‌
US Patent 8092797 Anti-VEGF antibodies
0
‌
US Patent 8092803 VEGF antagonist formulations for intravitreal administration
0
‌
US Patent 8101177 Anti-VEGF antibodies
0
‌
US Patent 8110546 VEGF antagonist formulations
0
‌
US Patent 8124076 Single chain antibodies against β-amyloid peptide
0
‌
US Patent 8147830 Antibody fragment-polymer conjugates and uses of same
0
‌
US Patent 8163726 Method of inhibiting choroidal neovascularization
0
‌
US Patent 8187597 Combination therapy for the treatment of ocular neovascular disorders
0
‌
US Patent 8206707 Combination therapy for the treatment of ocular neovascular disorders
0
‌
US Patent 8211864 Compositions and methods for the intracellular disruption of VEGF and VEGFR-2 by intraceptors
0
‌
US Patent 8216571 Fully human anti-VEGF antibodies and methods of using
0
‌
US Patent 8216575 Inhibition of neovascularization with a soluble chimeric protein comprising VEGF FLT-1 and KDR domains
0
‌
US Patent 8231907 Nanoparticles for delivery of active agents
0
‌
US Patent 8236312 VEGF-specific human antibody
0
‌
US Patent RE43672 Anti-IL-6 antibodies, compositions, methods and uses
0
‌
US Patent 8268314 Bispecific anti-VEGF/anti-ANG-2 antibodies
0
‌
US Patent 8273352 Humanized anti-factor D antibodies and uses thereof
0
‌
US Patent 8273353 Inhibitors of vascular endothelial growth factor activity
0
‌
US Patent 8309532 Therapeutic uses of inhibitors of RTP801
0
‌
US Patent 8318169 Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier
0
‌
US Patent 8324169 VEGF-activated ligands
0
‌
US Patent 8329866 Long acting VEGF inhibitors and methods of use
0
‌
US Patent 8349325 Soluble FMS-like tyrosine kinase-1 (sFLT-1) antibody and related composition, kit, methods of using, and materials and method for making
0
‌
US Patent 8388963 Antitumor combinations containing a VEGF-inhibiting agent and 5FU or a derivative thereof
0
‌
US Patent 8455622 Variant target binding agents and uses thereof
0
‌
US Patent 8486397 Anti-VEGF-C antibodies and methods using same
0
‌
US Patent 8492527 Anti-VEGF antibodies
0
‌
US Patent 8506962 Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier
0
‌
US Patent 8512699 Anti-VEGF antibodies
0
‌
US Patent 8546345 Compositions and methods for siRNA inhibition of angiogenesis
0
‌
US Patent 8557246 Fusion protein that directs vaccine antigens to antigen-presenting cells, and applications thereof
0
‌
US Patent 8571802 Method for determining optimum intraocular locations for drug delivery systems
0
‌
US Patent 8614235 CAI-based systems and methods for the localized treatment of ocular and other diseases
0
‌
US Patent 8632774 Antagonists of IL-6
0
‌
US Patent 8658633 Methods and compositions for treating conditions of the eye
0
‌
US Patent 8663639 Formulations for treating ocular diseases and conditions
0
‌
US Patent 8685397 Combination therapy for the treatment of ocular neovascular disorders
0
‌
US Patent 8691226 Humanized anti-human tumor necrosis factor alpha monoclonal antibody and sequence thereof
0
‌
US Patent 8703130 Bispecific anti-VEGF/anti-ANG-2 antibodies
0
‌
US Patent 8703133 Antibody variants
0
‌
US Patent 8753625 Use of complement inhibitors to treat ocular diseases
0
‌
US Patent 8765432 Targeted drug phosphorylcholine polymer conjugates
0
‌
US Patent 8785385 RTEF-1 variants and uses thereof
0
‌
US Patent 8790647 Treatment of vasculoproliferative conditions with Lrg1 anatgonists
0
‌
US Patent 8802129 Methods for treating retinopathy with extended therapeutic effect
0
‌
US Patent 8815236 Method for treating multiple sclerosis and crohn's disease
0
‌
US Patent 8822645 Prostaglandin E2 dual variable domain immunoglobulins and uses thereof
0
‌
US Patent 8834884 Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier
0
‌
US Patent 8846021 Acryloyloxyethylphosphorylcholine containing polymer conjugates and their preparation
0
‌
US Patent 8864869 Hearth roll in a continuous annealing furnace and its production method
0
‌
US Patent 8883157 Targeting rare human PCSK9 variants for cholesterol treatment
0
‌
US Patent 8883519 Oxidase activity of polymeric coated cerium oxide nanoparticles
0
‌
US Patent 8911768 Methods for treating retinopathy with extended therapeutic effect
0
‌
US Patent 8926972 Anti-angiogenesis fusion proteins
0
‌
US Patent 8945552 Bispecific, bivalent anti-VEGF/anti-ANG-2 antibodies
0
‌
US Patent 8962804 Meditopes and meditope-binding antibodies and uses thereof
0
‌
US Patent 8986692 Anti-VEGF monoclonal antibody and pharmaceutical composition comprising said antibody
0
‌
US Patent 9029508 Dual variable domain immunoglobulins and uses thereof
0
‌
US Patent 9045551 Anti-DLL4/VEGF dual variable domain immunoglobulin and uses thereof
0
‌
US Patent 9079953 Anti-VEGF antibodies and their uses
0
‌
US Patent 9125940 Compositions and methods for treating macular edema
0
‌
US Patent 9149427 Cell lines that secrete anti-angiogenic antibody-scaffolds and soluble receptors and uses thereof
0
‌
US Patent 9163093 Anti-DLL4/VEGF dual variable domain immunoglobulin and uses thereof
0
‌
US Patent 9214906 Systems and methods for providing high and low enable modes for controlling radio-frequency amplifiers
0
‌
US Patent 9217039 Anti-HER3 antibodies and compositions
0
‌
US Patent 9220631 Syringe
0
‌
US Patent 9226917 Photodynamic therapy for conditions of the eye
0
‌
US Patent 9241906 Materials and methods for delivering compositions to selected tissues
0
‌
US Patent 9254338 Use of a VEGF antagonist to treat angiogenic eye disorders
0
‌
US Patent 9265827 Anti-PDGFR-beta antibodies and uses thereof
0
‌
US Patent 9273113 Methods of inhibiting vascular endothelial growth factor activity
0
‌
US Patent 9334324 Podocalyxin-like-protein-1 binding antibody molecule
0
‌
US Patent 9353177 Anti-VEGF antibodies
0
‌
US Patent 9388180 Inhibitor compounds of phosphodiesterase type 10A
0
‌
US Patent 9388239 Anti-human VEGF antibodies with unusually strong binding affinity to human VEGF-A and cross reactivity to human VEGF-B
0
‌
US Patent 9409990 Methods of inhibiting tumor growth by antagonizing IL-6 receptor
0
‌
US Patent 9416180 Precision medicine by targeting VEGF-A variants for treatment of diabetic macular edema and branch retinal vein occlusion
0
‌
US Patent 9416210 Zwitterionic polymers with therapeutic moieties
0
‌
US Patent 9421256 Anti-VEGF antibody compositions and methods
0
‌
US Patent 9428575 Anti-granulysin antibodies and methods of use thereof
0
‌
US Patent 9567403 Bispecific antibodies which bind EGFR and VEGF
0
‌
US Patent 9575067 Polymeric carriers for immunohistochemistry and in situ hybridization
0
‌
US Patent 9650443 Fusion protein comprising anti-c-Met antibody and VEGF-binding fragment
0
‌
US Patent 9650444 Anti-PDGFR-beta antibodies and uses thereof
0
‌
US Patent 9657084 Fusion protein inhibiting angiogenesis or growth and use thereof
0
‌
US Patent 9669069 Use of a VEGF antagonist to treat angiogenic eye disorders
0
‌
US Patent 9682144 Composition comprising inhibitors of IRS-1 and of VEGF
0
‌
US Patent 9695233 Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the treatment of ocular vascular diseases
0
‌
US Patent 9708390 Compositions and methods for inhibiting PDGFRbeta and VEGF-A
0
‌
US Patent 9708396 Bispecific anti-VEGF/anti-ANG-2 antibodies
0
‌
US Patent 9708397 Treatment of vasculoproliferative conditions with Lrg1 antagonists
0
‌
US Patent 9815893 Anti-VEGF antibodies and their uses
0
‌
US Patent 9822174 Anti-VEGF antibody, and pharmaceutical composition for preventing, diagnosing or treating cancer or angiogenesis-related diseases, containing same
0
‌
US Patent 9840553 Dual PDGF/VEGF antagonists
0
‌
US Patent 9850514 Methods and compositions for preventing norleucine misincorporation into proteins
0
‌
US Patent 9914770 Cloning, expression and purification method for the preparation of ranibizumab
0
‌
US Patent 9931330 Methods and devices for the treatment of ocular diseases in human subjects
0
‌
US Patent 9937129 Materials and methods for delivering compositions to selected tissues
0
‌
US Patent 9943573 Treatment of ocular neovascularization using anti-VEGF proteins
0
‌
US Patent 9944720 Anti-DLL4/VEGF dual variable domain immunoglobulin and uses thereof
0
‌
US Patent 9962333 Timed release of substances to treat ocular disorders
0
‌
US Patent 10004788 Treatment of ocular neovascularization using anti-VEGF proteins
0
‌
US Patent 10035850 Methods for treating neovascular age-related macular degeneration
0
‌
US Patent 10072075 Optimized variants of anti-VEGF antibodies and methods of treatment thereof by reducing or inhibiting angiogenesis
0
‌
US Patent 10106605 Compositions and methods for antibodies targeting Epo
0
‌
US Patent 10130681 Use of a VEGF antagonist to treat angiogenic eye disorders
0
‌
US Patent 10184010 Dual-targeting protein binding specifically to DLL4 and VEGF and use thereof
0
‌
US Patent 10208124 Anti-CD160 specific antibodies for the treatment of eye disorders based on neoangiogenesis
0
‌
US Patent 10208355 Method of treatment for glioblastoma by administering a VEGF antagonist
0
‌
US Patent 10240207 Cancer treatment with c-met antagonists and correlation of the latter with HGF expression
0
‌
US Patent 10259862 VEGF-binding protein for blockade of angiogenesis
0
‌
US Patent 10363290 Butyrylcholinesterase zwitterionic polymer conjugates
0
‌
US Patent 10406226 Method of manufacturing VEGF antagonist fusion proteins
0
‌
US Patent 10421984 Methods for reducing norleucine misincorporation into proteins using a microorganism comprising a mutant metA allele
0
‌
US Patent 10456466 Anti-VEGF antibody
0
‌
US Patent 10456470 Diagnostic methods and compositions for treatment of glioblastoma
0
‌
US Patent 10464992 VEGF antagonist formulations suitable for intravitreal administration
0
‌
US Patent 10519226 VEGF neutralizing prodrugs for the treatment of ocular conditions
0
‌
US Patent 10526382 Human neutrophil gelatinase-associated lipocalin (hNGAL) muteins capable of binding angiopoietin-2 (Ang-2) and methods of use thereof
0
‌
US Patent 10548998 Multimodal silica-based nanoparticles
0
‌
US Patent 10568951 Pharmaceutical composition of an anti-VEGF antibody
0
‌
US Patent 10702608 Factor VIII zwitterionic polymer conjugates
0
‌
US Patent 10828345 Use of a VEGF antagonist to treat angiogenic eye disorders
0
‌
US Patent 10857205 Use of a VEGF antagonist to treat angiogenic eye disorders
0
‌
US Patent 10857231 Formulations of VEG antagonist fusion proteins and method of manufacturing them
0
‌
US Patent 10888601 Use of a VEGF antagonist to treat angiogenic eye disorders
0
‌
US Patent 11066465 Antibodies and conjugates thereof
0
‌
US Patent 11071771 Butyrylcholinesterase zwitterionic polymer conjugates
0
‌
US Patent 11584790 Complement factor D antagonist antibodies and conjugates thereof
0
‌
US Patent 11590235 Factor VIII zwitterionic polymer conjugates
0
‌
US Patent 6852816 Zwitterionic polymers
0
‌
US Patent 6870033 Antibody fragment-polymer conjugates and humanized anti-IL-8 monoclonal antibodies
0
‌
US Patent 6881557 Super humanized antibodies
0
‌
US Patent 6884879 Anti-VEGF antibodies
0
‌
US Patent 6887962 Processes based on atom (or group) transfer radical polymerization and novel (co)polymers having useful structures and properties
0
‌
US Patent 6956107 Inhibitors of complement activation
0
‌
US Patent 6979556 Separate-cistron contructs for secretion of aglycosylated antibodies from prokaryotes
0
‌
US Patent 6992176 Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
0
‌
US Patent 7019082 Polymers, supersoft elastomers and methods for preparing the same
0
‌
US Patent 7049373 Process for preparation of graft polymers
0
‌
US Patent 7052691 Methods of treating diabetes by blocking VEGF-mediated activity
0
‌
US Patent 7056455 Process for the preparation of nanostructured materials
0
‌
US Patent 7056509 Antibody methods for selectively inhibiting VEGF
0
‌
US Patent 7060269 Anti-VEGF antibodies
0
‌
US Patent 7060271 Inhibitory immunoglobulin polypeptides to human PDGF beta receptor
0
‌
US Patent 7064166 Process for monomer sequence control in polymerizations
0
‌
US Patent 7070959 Modified chimeric polypeptides with improved pharmacokinetic properties
0
‌
US Patent 7071159 Inhibitor of vascular endothelial cell growth factor
0
Patent Primary Examiner
‌
Marianne P Allen
0

Find more entities like US Patent 12071476 IL-6 antibodies and fusion constructs and conjugates thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo